Literature DB >> 29725917

Pain, Headache, and Other Non-motor Symptoms in Myasthenia Gravis.

Olivia Tong1, Leslie Delfiner2, Steven Herskovitz1.   

Abstract

PURPOSE OF REVIEW: Myasthenia gravis (MG) is traditionally conceptualized as a disease with purely motor manifestations. This paper reviews the supporting evidence and pathophysiology of non-motor symptoms in MG, including pain, headache, special sense and autonomic dysfunction, sleep disturbance, and cognitive and psychosocial issues. RECENT
FINDINGS: Work in this area has been limited. Recent studies have identified bodily pain and headache as common complaints in patients with MG. A growing literature also suggests that there may be an association of MG and sleep disturbance (both obstructive sleep apnea and sleep cycle dysfunction). Few studies suggest some measurable abnormalities of olfaction, gustation, audition, and autonomic function. The cognitive and psychosocial aspects of MG represent an emerging area of clinical and research interest, but large-scale data is sparse in the USA. The pathophysiology of MG is complex, and our understanding of the immunologic basis of this disease is expanding. The classic view of MG as a purely motor disorder may be incomplete. Recent work highlights non-motor symptoms that may impact patient management and quality of life.

Entities:  

Keywords:  Headache; Myasthenia gravis; Non-motor symptoms; Pain; Quality of life; Sleep disorder

Mesh:

Year:  2018        PMID: 29725917     DOI: 10.1007/s11916-018-0687-3

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  64 in total

1.  Olfactory and gustatory dysfunction in Myasthenia gravis: A study in Turkish patients.

Authors:  Hakan Tekeli; Mehmet G Senol; Aytug Altundag; Esin Yalcınkaya; Mustafa T Kendirli; Halit Yaşar; Murat Salihoglu; Omer Saglam; Melih Cayonu; Enver Cesmeci; Thomas Hummel
Journal:  J Neurol Sci       Date:  2015-06-27       Impact factor: 3.181

2.  Myasthenia gravis: sleep quality, quality of life, and disease severity.

Authors:  Elena Hernández Martínez-Lapiscina; Elena Hernández Martínez De Lapiscina; María Elena Erro; María Elena Erro Aguirre; Teresa Ayuso; Teresa Ayuso Blanco; Ivonne Jericó; Ivonne Jericó Pascual
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

3.  Myasthenia gravis with autoimmune autonomic neuropathy.

Authors:  S Vernino; W P Cheshire; V A Lennon
Journal:  Auton Neurosci       Date:  2001-05-14       Impact factor: 3.145

Review 4.  Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches.

Authors:  Krisy-Ann Thornby; Amy Henneman; Dana A Brown
Journal:  Ann Pharmacother       Date:  2015-03-10       Impact factor: 3.154

Review 5.  The early history of myasthenia gravis.

Authors:  Trevor Hughes
Journal:  Neuromuscul Disord       Date:  2005-11-09       Impact factor: 4.296

Review 6.  Sensory aspects in myasthenia gravis: A translational approach.

Authors:  Fidias E Leon-Sarmiento; Juan S Leon-Ariza; Diddier Prada; Daniel S Leon-Ariza; Carlos V Rizzo-Sierra
Journal:  J Neurol Sci       Date:  2016-07-09       Impact factor: 3.181

7.  Abnormal sympathetic hyper-reactivity in patients with myasthenia gravis: a prospective study.

Authors:  Garima Shukla; Salil Gupta; Vinay Goyal; Sumit Singh; Achal Srivastava; Madhuri Behari
Journal:  Clin Neurol Neurosurg       Date:  2012-06-05       Impact factor: 1.876

8.  Tacrolimus for myasthenia gravis: a clinical study of 212 patients.

Authors:  José M Ponseti; Josep Gamez; Jamal Azem; Manuel López-Cano; Ramón Vilallonga; Manuel Armengol
Journal:  Ann N Y Acad Sci       Date:  2007-12-20       Impact factor: 5.691

Review 9.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

10.  Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study.

Authors:  Yuriko Nagane; Hiroyuki Murai; Tomihiro Imai; Daisuke Yamamoto; Emiko Tsuda; Naoya Minami; Yasushi Suzuki; Tetsuya Kanai; Akiyuki Uzawa; Naoki Kawaguchi; Masayuki Masuda; Shingo Konno; Hidekazu Suzuki; Masashi Aoki; Kimiaki Utsugisawa
Journal:  BMJ Open       Date:  2017-02-23       Impact factor: 2.692

View more
  2 in total

1.  Academic and Employment Status in Patients With Generalized Myasthenia Gravis Treated With Eculizumab: A Case Series.

Authors:  Seung Ah Kang; Megan Sweeney; Raghav Govindarajan
Journal:  J Clin Neuromuscul Dis       Date:  2022-06-01

2.  Studying the relationship between clinical features and mental health among late-onset myasthenia gravis patients.

Authors:  Lu Yu; Li Qiu; Hao Ran; Qian Ma; Ya-Ru Lu; Wei-Bin Liu
Journal:  World J Psychiatry       Date:  2022-03-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.